Statin Reduces C-Reactive Protein and Interleukin-6 in Normocholesterolemic Patients with Acute Coronary Syndrome
Chonnam Medical Journal · 2008
DOI: 10.4068/cmj.2008.44.1.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chonnam Medical Journal, 2008. Verfasst von Ok Young Park und 12 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Many evidences suggest that atherosclerosis is an inflammatory disease and inflammatory markers can be an important prognostic factors in acute coronary syndrome.Hydroxymethylglutaryl (HMG-CoA) reductase inhibitors (statins) have been shown anti-inflammatory property that are independent of lipid-lowering effects.We evaluated the effects of 2-month treatment with simvastatin (40 mg/d, n=20) on plasma levels of circulating high-sensitivity C-reactive protein (hsCRP), inflammatory cytokines [tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6], and adhesion molecules [p-selectin and monocyte chemotactic peptide (MCP)-1] with placebo group (n=20) in 40 normocholesterolemic patients (LDL<130 mg/dl) with acute coronary syndrome.Simvastatin therapy significantly reduced plasma levels of total cholesterol and LDL-cholesterol (p=0.05,p=0.02, respectively) compared with placebo group.Simvastatin therapy also significantly reduced plasma levels of hsCRP and IL-6 (p=0.03,p=0.03, respectively) compared with placebo group.But, the reduction of hsCRP and IL-6 levels with simvastatin was unrelated to the degree of LDL-cholesterol's reduction.The effect of simvastatin on the reduction of hsCRP and IL-6, but not on the other inflammatory cytokines and adhesion molecules, have potential implications in the management of acute coronary syndrome with normocholesterolemia.
Zitieren
APA
Park, O. Y., Kim, S. H., Ahn, Y. K., Yun, N. S., Kim, J. H., Sim, D. S., Yoon, H. J., Kim, K. H., Park, H. W., Hong, Y. J., Jeong, M. H., Cho, J. G., & Park, J. C. (2008). Statin Reduces C-Reactive Protein and Interleukin-6 in Normocholesterolemic Patients with Acute Coronary Syndrome. Chonnam Medical Journal. https://doi.org/10.4068/cmj.2008.44.1.13
Vancouver
Park OY, Kim SH, Ahn YK, Yun NS, Kim JH, Sim DS, et al. Statin Reduces C-Reactive Protein and Interleukin-6 in Normocholesterolemic Patients with Acute Coronary Syndrome. Chonnam Medical Journal. 2008. doi:10.4068/cmj.2008.44.1.13
BibTeX
@article{Park2008,
author = {Park, Ok Young and Kim, Soo Hang and Ahn, Young Keun and Yun, Nam Sik and Kim, Ju Han and Sim, Du Sun and Yoon, Hyun Ju and Kim, Kye Hun and Park, Hyung Wook and Hong, Young Joon and Jeong, Myung Ho and Cho, Jeong Gwan and Park, Jong Chun},
title = {Statin Reduces C-Reactive Protein and Interleukin-6 in Normocholesterolemic Patients with Acute Coronary Syndrome},
journal = {Chonnam Medical Journal},
year = {2008},
doi = {10.4068/cmj.2008.44.1.13}
}
EUVIMED